Nashville General Hospital — Nashville, Tennessee

Nashville General Hospital is a clinical research site located in Nashville, Tennessee, United States 37208.

Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Nashville General Hospital has participated in 10 clinical trials with 5 currently active.

Therapeutic areas: Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms.

Sponsors: Merck Sharp & Dohme LLC, Duke University, Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nashville General Hospital?

Nashville General Hospital has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nashville General Hospital conducted?

Nashville General Hospital has 10 clinical trials on record, with 5 currently active. Their work covers Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms.

Is Nashville General Hospital accredited by Crixeo Clinical Trials?

Nashville General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nashville General Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.